|
1
|
Devi KP, Malar DS, Nabavi SF, Sureda A,
Xiao J, Nabavi SM and Daglia M: Kaempferol and inflammation: From
chemistry to medicine. Pharmacol Res. 99:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsao R: Chemistry and biochemistry of
dietary polyphenols. Nutrients. 2:1231–1246. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calderón-Montaño JM, Burgos-Morón E,
Pérez-Guerrero C and López-Lázaro M: A review on the dietary
flavonoid kaempferol. Mini Rev Med Chem. 11:298–344. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park JS, Rho HS, Kim DH and Chang IS:
Enzymatic preparation of kaempferol from green tea seed and its
antioxidant activity. J Agric Food Chem. 54:2951–2956. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen AY and Chen YC: A review of the
dietary flavonoid, kaempferol on human health and cancer
chemoprevention. Food Chem. 138:2099–2107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yadav KS and Sawant KK: Modified
nanoprecipitation method for preparation of cytarabine-loaded PLGA
nanoparticles. AAPS PharmSciTech. 11:1456–1465. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hegde A and Bhatia M: Hydrogen sulfide in
inflammation: Friend or foe? Inflamm Allergy Drug Targets.
10:118–122. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Folkerts G, Kloek J, Muijsers RB and
Nijkamp FP: Reactive nitrogen and oxygen species in airway
inflammation. Eur J Pharmacol. 429:251–262. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin MK, Yu YL, Chen KC, Chang WT, Lee MS,
Yang MJ, Cheng HC, Liu CH, Chen DzC and Chu CL: Kaempferol from
Semen cuscutae attenuates the immune function of dendritic cells.
Immunobiology. 216:1103–1109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nosikova YS, Santerre JP, Grynpas M,
Gibson G and Kandel RA: Characterization of the annulus
fibrosus-vertebral body interface: Identification of new structural
features. J Anat. 221:577–589. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu J, Tang H, Zhang Z, Zhang Y, Qiu C,
Zhang L, Huang P and Li F: Kaempferol slows intervertebral disc
degeneration by modifying LPS-induced osteogenesis/adipogenesis
imbalance and inflammation response in BMSCs. Int Immunopharmacol.
43:236–242. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Silverwood V, Blagojevic-Bucknall M, Jinks
C, Jordan JL, Protheroe J and Jordan KP: Current evidence on risk
factors for knee osteoarthritis in older adults: A systematic
review and meta-analysis. Osteoarthritis Cartilage. 23:507–515.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Asanbaeva A, Tam J, Schumacher BL, Klisch
SM, Masuda K and Sah RL: Articular cartilage tensile integrity:
Modulation by matrix depletion is maturation-dependent. Arch
Biochem Biophys. 474:175–182. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lawrence RC, Felson DT, Lawrence RC,
Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD,
Merkel PA, et al: Estimates of the prevalence of arthritis and
other rheumatic conditions in the United States. Part II. Arthritis
Rheum. 58:15–25. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu-Bryan R and Terkeltaub R: Emerging
regulators of the inflammatory process in osteoarthritis. Nat Rev
Rheumatol. 11:35–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abramson SB: Osteoarthritis and nitric
oxide. Osteoarthritis Cartilage. 16 (Suppl 2):S15–S20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Honghai Z, Zhang T, Xia C, Shi L, Wang S,
Zheng X, Hu T and Zhang B: Berberine ameliorates cartilage
degeneration in interleukin-1β-stimulated rat chondrocytes and in a
rat model of osteoarthritis via Akt signalling. J Cell Mol Med.
18:283–292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park MY, Ji GE and Sung MK: Dietary
kaempferol suppresses inflammation of dextran sulfate
sodium-induced colitis in mice. Dig Dis Sci. 57:355–363. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sordillo LM and Streicher KL: Mammary
gland immunity and mastitis susceptibility. J Mammary Gland Biol
Neoplasia. 7:135–146. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiao HB, Sui GG, Lu XY and Sun ZL:
Kaempferol modulates Angiopoietin-like protein 2 expression to
lessen the mastitis in mice. Pharmacol Rep. 70:439–445. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alam J, Jantan I and Bukhari SNA:
Rheumatoid arthritis: Recent advances on its etiology, role of
cytokines and pharmacotherapy. Biomed Pharmacother. 92:615–633.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pan D, Li N, Liu Y, Xu Q, Liu Q, You Y,
Wei Z, Jiang Y, Liu M, Guo T, et al: Kaempferol inhibits the
migration and invasion of rheumatoid arthritis fibroblast-like
synoviocytes by blocking activation of the MAPK pathway. Int
Immunopharmacol. 55:174–182. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee CJ, Moon SJ, Jeong JH, Lee S, Lee MH,
Yoo SM, Lee HS, Kang HC, Lee JY, Lee WS, et al: Kaempferol
targeting on the fibroblast growth factor receptor 3-ribosomal S6
kinase 2 signaling axis prevents the development of rheumatoid
arthritis. Cell Death Dis. 9:4012018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gill SE, Rohan M and Mehta S: Role of
pulmonary microvascular endothelial cell apoptosis in murine
sepsis-induced lung injury in vivo. Respir Res. 16:1092015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Villar J, Blanco J, Añón JM, Santos-Bouza
A, Blanch L, Ambrós A, Gandía F, Carriedo D, Mosteiro F, Basaldúa
S, et al: The ALIEN study: Incidence and outcome of acute
respiratory distress syndrome in the era of lung protective
ventilation. Intensive Care Med. 37:1932–1941. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Matthay MA and Zimmerman GA: Acute lung
injury and the acute respiratory distress syndrome: Four decades of
inquiry into pathogenesis and rational management. Am J Respir Cell
Mol Biol. 33:319–327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang R, Ai X, Duan Y, Xue M, He W, Wang
C, Xu T, Xu M, Liu B, Li C, et al: Kaempferol ameliorates H9N2
swine influenza virus-induced acute lung injury by inactivation of
TLR4/MyD88-mediated NF-κB and MAPK signaling pathways. Biomed.
Pharmacother. 89:660–672. 2017. View Article : Google Scholar
|
|
28
|
Rabha DJ, Singh TU, Rungsung S, Kumar T,
Parida S, Lingaraju MC, Paul A, Sahoo M and Kumar D: Kaempferol
attenuates acute lung injury in caecal ligation and puncture model
of sepsis in mice. Exp Lung Res. 44:63–78. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen X, Yang X, Liu T, Guan M, Feng X,
Dong W, Chu X, Liu J, Tian X, Ci X, et al: Kaempferol regulates
MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute
lung injury in mice. Int Immunopharmacol. 14:209–216. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gong JH, Shin D, Han SY, Kim JL and Kang
YH: Kaempferol suppresses eosionphil infiltration and airway
inflammation in airway epithelial cells and in mice with allergic
asthma. J Nutr. 142:47–56. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Banerjee R and Puniyani RR: Exogenous
surfactant therapy and mucus rheology in chronic obstructive airway
diseases. J Biomater Appl. 14:243–272. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Davies DE: The role of the epithelium in
airway remodeling in asthma. Proc Am Thorac Soc. 6:678–682. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Erjefält JS: The airway epithelium as
regulator of inflammation patterns in asthma. Clin Respir J. 4
(Suppl 1):S9–S14. 2010. View Article : Google Scholar
|
|
34
|
Kim SR and Lee YC: Endoplasmic reticulum
stress and the related signaling networks in severe asthma. Allergy
Asthma Immunol Res. 7:106–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Makhija L, Krishnan V, Rehman R,
Chakraborty S, Maity S, Mabalirajan U, Chakraborty K, Ghosh B and
Agrawal A: Chemical chaperones mitigate experimental asthma by
attenuating endoplasmic reticulum stress. Am J Respir Cell Mol
Biol. 50:923–931. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Park SH, Gong JH, Choi YJ, Kang MK, Kim YH
and Kang YH: Kaempferol inhibits endoplasmic reticulum
stress-associated mucus hypersecretion in airway epithelial cells
and ovalbumin-sensitized mice. PLoS One. 10:e01435262015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lopez-Basave HN, Morales-Vásquez F,
Ruiz-Molina JM, Namendys-Silva SA, Vela-Sarmiento I, Ruan JM,
Rosciano AE, Calderillo-Ruiz G, Díaz-Romero C, Herrera-Gómez A and
Meneses-García AA: Gastric cancer in young people under 30 years of
age: Worse prognosis, or delay in diagnosis? Cancer Manag Res.
5:31–36. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li WF, Hao DJ, Fan T, Huang HM, Yao H and
Niu XF: Protective effect of chelerythrine against ethanol-induced
gastric ulcer in mice. Chem Biol Interact. 208:18–27. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bae S, Kim N, Kang JM, Kim DS, Kim KM, Cho
YK, Kim JH, Jung SW and Shim KN: Incidence and 30-day mortality of
peptic ulcer bleeding in Korea. Eur J Gastroenterol Hepatol.
24:675–682. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ribeiro AR, Diniz PB, Pinheiro MS,
Albuquerque-Júnior RL and Thomazzi SM: Gastroprotective effects of
thymol on acute and chronic ulcers in rats: The role of
prostaglandins, ATP-sensitive K(+) channels, and gastric mucus
secretion. Chem Biol Interact. 244:121–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ateufack G, Domgnim Mokam EC, Mbiantcha M,
Dongmo Feudjio RB, David N and Kamanyi A: Gastroprotective and
ulcer healing effects of Piptadeniastrum Africanum on
experimentally induced gastric ulcers in rats. BMC Complement
Altern Med. 15:2142015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Almasaudi SB, Abbas AT, Al-Hindi RR,
El-Shitany NA, Abdel-Dayem UA, Ali SS, Saleh RM, Al Jaouni SK,
Kamal MA and Harakeh SM: Manuka honey exerts antioxidant and
anti-inflammatory activities that promote healing of acetic
acid-induced gastric ulcer in rats. Evid Based Complement Alternat
Med. 2017:54139172017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Niv Y and Banić M: Gastric barrier
function and toxic damage. Dig Dis. 32:235–242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hajrezaie M, Golbabapour S, Hassandarvish
P, Gwaram NS, A Hadi AH, Mohd Ali H, Majid N and Abdulla MA: Acute
toxicity and gastroprotection studies of a new schiff base derived
copper (II) complex against ethanol-induced acute gastric lesions
in rats. PLoS One. 7:e515372012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li Q, Hu X, Xuan Y, Ying J, Fei Y, Rong J,
Zhang Y, Zhang J, Liu C and Liu Z: Kaempferol protects
ethanol-induced gastric ulcers in mice via pro-inflammatory
cytokines and NO. Acta Biochim Biophys Sin (Shanghai). 50:246–253.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Arif H, Sohail A, Farhan M, Rehman AA,
Ahmad A and Hadi SM: Flavonoids-induced redox cycling of copper
ions leads to generation of reactive oxygen species: A potential
role in cancer chemoprevention. Int J Biol Macromol. 106:569–578.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bandla S, Pennathur A, Luketich JD, Beer
DG, Lin L, Bass AJ, Godfrey TE and Litle VR: Comparative genomics
of esophageal adenocarcinoma and squamous cell carcinoma. Ann
Thorac Surg. 93:1101–1106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pohl H and Welch HG: The role of
overdiagnosis and reclassification in the marked increase of
esophageal adenocarcinoma incidence. J Natl Cancer Inst.
97:142–146. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yao S, Wang X, Li C, Zhao T, Jin H and
Fang W: Kaempferol inhibits cell proliferation and glycolysis in
esophagus squamous cell carcinoma via targeting EGFR signaling
pathway. Tumour Biol. 37:10247–10256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang Q, Zhao XH and Wang ZJ: Flavones and
flavonols exert cytotoxic effects on a human oesophageal
adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing
apoptosis. Food Chem Toxicol. 46:2042–2053. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Diantini A, Subarnas A, Lestari K, Halimah
E, Susilawati Y, Supriyatna, Julaeha E, Achmad TH, Suradji EW,
Yamazaki C, et al: Kaempferol-3-O-rhamnoside isolated from the
leaves of Schima wallichii Korth. inhibits MCF-7 breast cancer cell
proliferation through activation of the caspase cascade pathway.
Oncol Lett. 3:1069–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kim SH, Hwang KA and Choi KC: Treatment
with kaempferol suppresses breast cancer cell growth caused by
estrogen and triclosan in cellular and xenograft breast cancer
models. J Nutr Biochem. 28:70–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ren W, Qiao Z, Wang H, Zhu L and Zhang L:
Flavonoids: Promising anticancer agents. Med Res Rev. 23:519–534.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Konopleva M, Zhao S, Xie Z, Segall H,
Younes A, Claxton DF, Estrov Z, Kornblau SM and Andreeff M:
Apoptosis. Molecules and mechanisms. Adv Exp Med Biol. 457:217–236.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li S, Yan T, Deng R, Jiang X, Xiong H,
Wang Y, Yu Q, Wang X, Chen C and Zhu Y: Low dose of kaempferol
suppresses the migration and invasion of triple-negative breast
cancer cells by downregulating the activities of RhoA and Rac1.
Onco Targets Ther. 10:4809–4819. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yi X, Zuo J, Tan C, Xian S, Luo C, Chen S,
Yu L and Luo Y: Kaempferol, a flavonoid compound from induced
apoptosis and growth inhibition in MCF-7 breast cancer cell. Afr J
Tradit Complement Altern Med. 13:210–215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhu L and Xue L: Kaempferol suppresses
proliferation and induces cell cycle arrest, apoptosis, and DNA
damage in breast cancer cells. Oncol Res. 27:629–634. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kashafi E, Moradzadeh M, Mohamadkhani A
and Erfanian S: Kaempferol increases apoptosis in human cervical
cancer HeLa cells via PI3K/AKT and telomerase pathways. Biomed
Pharmacother. 89:573–577. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Guo H, Ren F, Zhang L, Zhang X, Yang R,
Xie B, Li Z, Hu Z, Duan Z and Zhang J: Kaempferol induces apoptosis
in HepG2 cells via activation of the endoplasmic reticulum stress
pathway. Mol Med Rep. 13:2791–2800. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Semenza GL: Defining the role of
hypoxia-inducible factor 1 in cancer biology and therapeutics.
Oncogene. 29:625–634. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Calvisi DF, Ladu S, Gorden A, Farina M,
Conner EA, Lee JS, Factor VM and Thorgeirsson SS: Ubiquitous
activation of Ras and Jak/Stat pathways in human HCC.
Gastroenterology. 130:1117–1128. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Bruix J and Llovet JM: Major achievements
in hepatocellular carcinoma. Lancet. 373:614–616. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Mylonis I, Lakka A, Tsakalof A and Simos
G: The dietary flavonoid kaempferol effectively inhibits HIF-1
activity and hepatoma cancer cell viability under hypoxic
conditions. Biochem Biophys Res Commun. 398:74–78. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Seydi E, Salimi A, Rasekh HR, Mohsenifar Z
and Pourahmad J: Selective cytotoxicity of luteolin and kaempferol
on cancerous hepatocytes obtained from rat model of hepatocellular
carcinoma: Involvement of ROS-mediated mitochondrial targeting.
Nutr Cancer. 70:594–604. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Luo H, Rankin GO, Li Z, Depriest L and
Chen YC: Kaempferol induces apoptosis in ovarian cancer cells
through activating p53 in the intrinsic pathway. Food Chem.
128:513–519. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Mellier G, Huang S, Shenoy K and Pervaiz
S: TRAILing death in cancer. Mol Aspects Med. 31:93–112. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Inoue T, Shiraki K, Fuke H, Yamanaka Y,
Miyashita K, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K and Nakano
T: Proteasome inhibition sensitizes hepatocellular carcinoma cells
to TRAIL by suppressing caspase inhibitors and AKT pathway.
Anticancer Drugs. 17:261–268. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhao Y, Tian B, Wang Y and Ding H:
Kaempferol sensitizes human ovarian cancer cells-OVCAR-3 and SKOV-3
to tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL)-induced apoptosis via JNK/ERK-CHOP pathway and
Up-regulation of death receptors 4 and 5. Med Sci Monit.
23:5096–5105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Bartek J and Lukas J: Chk1 and Chk2
kinases in checkpoint control and cancer. Cancer Cell. 3:421–429.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Gao Y, Yin J, Rankin GO and Chen YC:
Kaempferol induces G2/M cell cycle arrest via checkpoint Kinase 2
and promotes apoptosis via death receptors in human ovarian
carcinoma A2780/CP70 cells. Molecules. 23(pii): E10952018.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Hundahl SA, Menck HR, Mansour EG and
Winchester DP: The national cancer data base report on gastric
carcinoma. Cancer. 80:2333–2341. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Alberts SR, Cervantes A and van de Velde
CJ: Gastric cancer: Epidemiology, pathology and treatment. Ann
Oncol. 14 (Suppl 2):ii31–ii36. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ajani JA: Evolving chemotherapy for
advanced gastric cancer. Oncologist. 10 (Suppl 3):S49–S58. 2005.
View Article : Google Scholar
|
|
75
|
Roberts AB and Wakefield LM: The two faces
of transforming growth factor beta in carcinogenesis. Proc Natl
Acad Sci USA. 100:8621–8623. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
DiMagno EP, Reber HA and Tempero MA: AGA
technical review on the epidemiology, diagnosis, and treatment of
pancreatic ductal adenocarcinoma. American Gastroenterological
Association. Gastroenterology. 117:1464–1484. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Jo E, Park SJ, Choi YS, Jeon WK and Kim
BC: Kaempferol suppresses transforming growth factor-β1-induced
Epithelial-to-Mesenchymal transition and migration of A549 lung
cancer cells by inhibiting Akt1-mediated phosphorylation of Smad3
at threonine-179. Neoplasia. 17:525–537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
McCoyd M, Gruener G and Foy P: Neurologic
aspects of lymphoma and leukemias. Handb Clin Neurol.
120:1027–1043. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Wu LY, Lu HF, Chou YC, Shih YL, Bau DT,
Chen JC, Hsu SC and Chung JG: Kaempferol induces DNA damage and
inhibits DNA repair associated protein expressions in human
promyelocytic leukemia HL-60 cells. Am J Chin Med. 43:365–382.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Adams J and Nassiri M: Acute Promyelocytic
leukemia: A review and discussion of variant translocations. Arch
Pathol Lab Med. 139:1308–1313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Moradzadeh M, Tabarraei A, Sadeghnia HR,
Ghorbani A, Mohamadkhani A, Erfanian S and Sahebkar A: Kaempferol
increases apoptosis in human acute promyelocytic leukemia cells and
inhibits multidrug resistance genes. J Cell Biochem. 119:2288–2297.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Song W, Dang Q, Xu D, Chen Y, Zhu G, Wu K,
Zeng J, Long Q, Wang X, He D and Li L: Kaempferol induces cell
cycle arrest and apoptosis in renal cell carcinoma through EGFR/p38
signaling. Oncol Rep. 31:1350–1356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Qin Y, Cui W, Yang X and Tong B:
Kaempferol inhibits the growth and metastasis of cholangiocarcinoma
in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai).
48:238–245. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Neoptolemos JP, Dunn JA, Stocken DD,
Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P,
Dervenis C, et al: Adjuvant chemoradiotherapy and chemotherapy in
resectable pancreatic cancer: A randomised controlled trial.
Lancet. 358:1576–1585. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Brandes F, Schmidt K, Wagner C, Redekopf
J, Schlitt HJ, Geissler EK and Lang SA: Targeting cMET with INC280
impairs tumour growth and improves efficacy of gemcitabine in a
pancreatic cancer model. BMC Cancer. 15:712015. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Di Renzo MF, Poulsom R, Olivero M,
Comoglio PM and Lemoine NR: Expression of the Met/hepatocyte growth
factor receptor in human pancreatic cancer. Cancer Res.
55:1129–1138. 1995.PubMed/NCBI
|
|
87
|
Lee J and Kim JH: Kaempferol inhibits
pancreatic cancer cell growth and migration through the blockade of
EGFR-related pathway in vitro. PLoS One. 11:e01552642016.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Liang J, Wu L, Xiao H, Li N, Wang H, Cheng
C, Bai R, Zhao Y and Zheng H: Use of myocardin in the
classification of mesenchymal tumors of the uterus. Int J Gynecol
Pathol. 29:55–62. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Li Y, Ding Z and Wu C: Mechanistic study
of the inhibitory effect of kaempferol on uterine fibroids in
vitro. Med Sci Monit. 22:4803–4808. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Qiu W, Lin J, Zhu Y, Zhang J, Zeng L, Su M
and Tian Y: Kaempferol modulates DNA methylation and downregulates
DNMT3B in bladder cancer. Cell Physiol Biochem. 41:1325–1335. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Azad N, Zahnow CA, Rudin CM and Baylin SB:
The future of epigenetic therapy in solid tumours-lessons from the
past. Nat Rev Clin Oncol. 10:256–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Maio M, Covre A, Fratta E, Di Giacomo AM,
Taverna P, Natali PG, Coral S and Sigalotti L: Molecular pathways:
At the crossroads of cancer epigenetics and immunotherapy. Clin
Cancer Res. 21:4040–4047. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Lee SJ, Park SS, Kim WJ and Moon SK:
Gleditsia sinensis thorn extract inhibits proliferation and
TNF-α-induced MMP-9 expression in vascular smooth muscle cells. Am
J Chin Med. 40:373–386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Kansara M and Thomas DM: Molecular
pathogenesis of osteosarcoma. DNA Cell Biol. 26:1–18. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Huang WW, Chiu YJ, Fan MJ, Lu HF, Yeh HF,
Li KH, Chen PY, Chung JG and Yang JS: Kaempferol induced apoptosis
via endoplasmic reticulum stress and mitochondria-dependent pathway
in human osteosarcoma U-2 OS cells. Mol Nutr Food Res.
54:1585–1595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Chen HJ, Lin CM, Lee CY, Shih NC, Peng SF,
Tsuzuki M, Amagaya S, Huang WW and Yang JS: Kaempferol suppresses
cell metastasis via inhibition of the ERK-p38-JNK and AP-1
signaling pathways in U-2 OS human osteosarcoma cells. Oncol Rep.
30:925–932. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Alter MJ: Epidemiology of viral hepatitis
and HIV co-infection. J Hepatol. 44 (1 Suppl):S6–S9. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Lee SS, Buters JT, Pineau T,
Fernandez-Salguero P and Gonzalez FJ: Role of CYP2E1 in the
hepatotoxicity of acetaminophen. J Biol Chem. 271:12063–12067.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Nicod L, Viollon C, Regnier A, Jacqueson A
and Richert L: Rifampicin and isoniazid increase acetaminophen and
isoniazid cytotoxicity in human HepG2 hepatoma cells. Hum Exp
Toxicol. 16:28–34. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Shih TY, Young TH, Lee HS, Hsieh CB and Hu
OY: Protective effects of kaempferol on isoniazid- and
rifampicin-induced hepatotoxicity. AAPS J. 15:753–762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Rudnicki M, Silveira MM, Pereira TV,
Oliveira MR, Reginatto FH, Dal-Pizzol F and Moreira JC: Protective
effects of Passiflora alata extract pretreatment on carbon
tetrachloride induced oxidative damage in rats. Food Chem Toxicol.
45:656–661. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Sun F, Hamagawa E, Tsutsui C, Ono Y, Ogiri
Y and Kojo S: Evaluation of oxidative stress during apoptosis and
necrosis caused by carbon tetrachloride in rat liver. Biochim
Biophys Acta. 1535:186–191. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Szymonik-Lesiuk S, Czechowska G,
Stryjecka-Zimmer M, Słomka M, Madro A, Celiński K and Wielosz M:
Catalase, superoxide dismutase, and glutathione peroxidase
activities in various rat tissues after carbon tetrachloride
intoxication. J Hepatobiliary Pancreat Surg. 10:309–315. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Wang Y, Tang C and Zhang H:
Hepatoprotective effects of kaempferol 3-O-rutinoside and
kaempferol 3-O-glucoside from Carthamus tinctorius L. on
CCl4-induced oxidative liver injury in mice. J Food Drug
Anal. 23:310–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
O'Shea RS, Dasarathy S and McCullough AJ;
Practice Guideline Committee of the American Association for the
Study of Liver Diseases; Practice Parameters Committee of the
American College of Gastroenterology, : Alcoholic liver disease.
Hepatology. 51:307–328. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Wang M, Sun J, Jiang Z, Xie W and Zhang X:
Hepatoprotective effect of kaempferol against alcoholic liver
injury in mice. Am J Chin Med. 43:241–254. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
French SW: The importance of CYP2E1 in the
pathogenesis of alcoholic liver disease and drug toxicity and the
role of the proteasome. Subcell Biochem. 67:145–164. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zhou B, Jiang Z, Li X and Zhang X:
Kaempferol's protective effect on ethanol-induced mouse primary
hepatocytes injury involved in the synchronous inhibition of SP1,
Hsp70 and CYP2E1. Am J Chin Med. 46:1093–1110. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
McCarthy MI: Genomics, type 2 diabetes,
and obesity. N Engl J Med. 363:2339–2350. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Tilg H and Moschen AR: Adipocytokines:
Mediators linking adipose tissue, inflammation and immunity. Nat
Rev Immunol. 6:772–873. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Lee B, Kwon M, Choi JS, Jeong HO, Chung HY
and Kim HR: Kaempferol isolated from nelumbo nucifera inhibits
lipid accumulation and increases fatty acid oxidation signaling in
adipocytes. J Med Food. 18:1363–1370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Chang CJ, Tzeng TF, Liou SS, Chang YS and
Liu IM: Kaempferol regulates the lipid-profile in high-fat diet-fed
rats through an increase in hepatic PPARα levels. Planta Med.
77:1876–1882. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Luo C, Yang H, Tang C, Yao G, Kong L, He H
and Zhou Y: Kaempferol alleviates insulin resistance via hepatic
IKK/NF-κB signal in type 2 diabetic rats. Int Immunopharmacol.
28:744–750. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Chen X, Qian J, Wang L, Li J, Zhao Y, Han
J, Khan Z, Chen X, Wang J and Liang G: Kaempferol attenuates
hyperglycemia-induced cardiac injuries by inhibiting inflammatory
responses and oxidative stress. Endocrine. 60:83–94. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zhang Y and Liu D: Flavonol kaempferol
improves chronic hyperglycemia-impaired pancreatic beta-cell
viability and insulin secretory function. Eur J Pharmacol.
670:325–332. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Kass DA: Getting better without AGE: New
insights into the diabetic heart. Circ Res. 92:704–706. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Suchal K, Malik S, Khan SI, Malhotra RK,
Goyal SN, Bhatia J, Ojha S and Arya DS: Molecular pathways involved
in the amelioration of myocardial injury in diabetic rats by
kaempferol. Int J Mol Sci. 18(pii): E10012017. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Alkhalidy H, Moore W, Wang A, Luo J,
McMillan RP, Wang Y, Zhen W, Hulver MW and Liu D: Kaempferol
ameliorates hyperglycemia through suppressing hepatic
gluconeogenesis and enhancing hepatic insulin sensitivity in
diet-induced obese mice. J Nutr Biochem. 58:90–101. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Kishore L, Kaur N and Singh R: Effect of
Kaempferol isolated from seeds of Eruca sativa on changes of pain
sensitivity in Streptozotocin-induced diabetic neuropathy.
Inflammopharmacology. 26:993–1003. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Chawla A, Repa JJ, Evans RM and
Mangelsdorf DJ: Nuclear receptors and lipid physiology: Opening the
X-files. Science. 294:1866–1870. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Hoang MH, Jia Y, Mok B, Jun HJ, Hwang KY
and Lee SJ: Kaempferol ameliorates symptoms of metabolic syndrome
by regulating activities of liver X receptor-β. J Nutr Biochem.
26:868–875. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Fisher M: Injuries to the vascular
endothelium: Vascular wall and endothelial dysfunction. Rev Neurol
Dis. 5 (Suppl 1):S4–S11. 2008.PubMed/NCBI
|
|
124
|
Kim TH, Ku SK and Bae JS: Inhibitory
effects of kaempferol-3-O-sophoroside on HMGB1-mediated
proinflammatory responses. Food Chem Toxicol. 50:1118–1123. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
ten Dijke P and Arthur HM: Extracellular
control of TGFbeta signalling in vascular development and disease.
Nat Rev Mol Cell Biol. 8:857–869. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Chan MC, Hilyard AC, Wu C, Davis BN, Hill
NS, Lal A, Lieberman J, Lagna G and Hata A: Molecular basis for
antagonism between PDGF and the TGFbeta family of signalling
pathways by control of miR-24 expression. EMBO J. 29:559–573. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Kim K, Kim S, Moh SH and Kang H:
Kaempferol inhibits vascular smooth muscle cell migration by
modulating BMP-mediated miR-21 expression. Mol Cell Biochem.
407:143–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Ochiai A, Miyata S, Iwase M, Shimizu M,
Inoue J and Sato R: Kaempferol stimulates gene expression of
low-density lipoprotein receptor through activation of Sp1 in
cultured hepatocytes. Sci Rep. 6:249402016. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Tabas I, García-Cardeña G and Owens GK:
Recent insights into the cellular biology of atherosclerosis. J
Cell Biol. 209:13–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Singh M, Ananthula S, Milhorn DM,
Krishnaswamy G and Singh K: Osteopontin: A novel inflammatory
mediator of cardiovascular disease. Front Biosci. 12:214–221. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Xiao HB, Lu XY, Sun ZL and Zhang HB:
Kaempferol regulates OPN-CD44 pathway to inhibit the atherogenesis
of apolipoprotein E deficient mice. Toxicol Appl Pharmacol.
257:405–411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Keys A, Taylor HL, Blackburn H, Brozek J,
Anderson JT and Simonson E: Mortality and coronary heart disease
among men studied for 23 years. Arch Intern Med. 128:201–214. 1971.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Che J, Liang B, Zhang Y, Wang Y, Tang J
and Shi G: Kaempferol alleviates ox-LDL-induced apoptosis by
up-regulation of autophagy via inhibiting PI3K/Akt/mTOR pathway in
human endothelial cells. Cardiovasc Pathol. 31:57–62. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Weisel JW, Stauffacher CV, Bullitt E and
Cohen C: A model for fibrinogen: Domains and sequence. Science.
230:1388–1391. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Choi JH, Park SE, Kim SJ and Kim S:
Kaempferol inhibits thrombosis and platelet activation. Biochimie.
115:177–186. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Mackman N: Triggers, targets and
treatments for thrombosis. Nature. 451:914–918. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Begonja AJ, Gambaryan S, Geiger J, Aktas
B, Pozgajova M, Nieswandt B and Walter U: Platelet
NAD(P)H-oxidase-generated ROS production regulates
alphaIIbbeta3-integrin activation independent of the NO/cGMP
pathway. Blood. 106:2757–2760. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Wang SB, Jang JY, Chae YH, Min JH, Baek
JY, Kim M, Park Y, Hwang GS, Ryu JS and Chang TS: Kaempferol
suppresses collagen-induced platelet activation by inhibiting NADPH
oxidase and protecting SHP-2 from oxidative inactivation. Free
Radic Biol Med. 83:41–53. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Hampton BM, Schwartz SG, Brantley MA Jr
and Flynn HW Jr: Update on genetics and diabetic retinopathy. Clin
Ophthalmol. 9:2175–2193. 2015.PubMed/NCBI
|
|
140
|
Behl T and Kotwani A: Exploring the
various aspects of the pathological role of vascular endothelial
growth factor (VEGF) in diabetic retinopathy. Pharmacol Res.
99:137–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Jenkins AJ, Joglekar MV, Hardikar AA,
Keech AC, O'Neal DN and Januszewski AS: Biomarkers in diabetic
retinopathy. Rev Diabet Stud. 12:159–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Li JK, Wei F, Jin XH, Dai YM, Cui HS and
Li YM: Changes in vitreous VEGF, bFGF and fibrosis in proliferative
diabetic retinopathy after intravitreal bevacizumab. Int J
Ophthalmol. 8:1202–1206. 2015.PubMed/NCBI
|
|
143
|
Sorenson CM, Wang S, Gendron R, Paradis H
and Sheibani N: Thrombospondin-1 deficiency exacerbates the
pathogenesis of diabetic retinopathy. J Diabetes Metab. (Suppl
12):2013.doi: 10.4172/2155-6156.S12-005. PubMed/NCBI
|
|
144
|
Wu Y, Zhang Q and Zhang R: Kaempferol
targets estrogen-related receptor a and suppresses the angiogenesis
of human retinal endothelial cells under high glucose conditions.
Exp Ther Med. 14:5576–5582. 2017.PubMed/NCBI
|
|
145
|
Xu XH, Zhao C, Peng Q, Xie P and Liu QH:
Kaempferol inhibited VEGF and PGF expression and in vitro
angiogenesis of HRECs under diabetic-like environment. Braz J Med
Biol Res. 50:e53962017. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Chin HK, Horng CT, Liu YS, Lu CC, Su CY,
Chen PS, Chiu HY, Tsai FJ, Shieh PC and Yang JS: Kaempferol
inhibits angiogenic ability by targeting VEGF receptor-2 and
downregulating the PI3K/AKT, MEK and ERK pathways in
VEGF-stimulated human umbilical vein endothelial cells. Oncol Rep.
39:2351–2357. 2018.PubMed/NCBI
|
|
147
|
Zhang YW, Shi J, Li YJ and Wei L:
Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch
Immunol Ther Exp (Warsz). 57:435–445. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Kawamura T, Hasegawa K, Morimoto T,
Iwai-Kanai E, Miyamoto S, Kawase Y, Ono K, Wada H, Akao M and Kita
T: Expression of p300 protects cardiac myocytes from apoptosis in
vivo. Biochem Biophys Res Commun. 315:733–738. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Xiao J, Sun GB, Sun B, Wu Y, He L, Wang X,
Chen RC, Cao L, Ren XY and Sun XB: Kaempferol protects against
doxorubicin-induced cardiotoxicity in vivo and in vitro.
Toxicology. 292:53–62. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Liu J, Xin L, Benson VL, Allen DG and Ju
YK: Store-operated calcium entry and the localization of STIM1 and
Orai1 proteins in isolated mouse sinoatrial node cells. Front
Physiol. 6:692015. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Swulius MT and Waxham MN:
Ca(2+)/calmodulin-dependent protein kinases. Cell Mol Life Sci.
65:2637–2657. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Wang Y, Cui H, Wang W, Zhao B and Lai J:
The region-specific activation of Ca2+/calmodulin dependent protein
kinase II and extracellular signal-regulated kinases in hippocampus
following chronic alcohol exposure. Brain Res Bull. 89:191–196.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Swaminathan PD, Purohit A, Soni S, Voigt
N, Singh MV, Glukhov AV, Gao Z, He BJ, Luczak ED, Joiner ML, et al:
Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J
Clin Invest. 121:3277–3288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Schiattarella GG and Hill JA: Inhibition
of hypertrophy is a good therapeutic strategy in ventricular
pressure overload. Circulation. 131:1435–1447. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Rose BA, Force T and Wang Y:
Mitogen-activated protein kinase signaling in the heart: Angels
versus demons in a heart-breaking tale. Physiol Rev. 90:1507–1546.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Feng H, Cao J, Zhang G and Wang Y:
Kaempferol attenuates cardiac hypertrophy via regulation of
ASK1/MAPK signaling pathway and oxidative stress. Planta Med.
83:837–845. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Weng X, Yu L, Liang P, Chen D, Cheng X,
Yang Y, Li L, Zhang T, Zhou B, Wu X, et al: Endothelial MRTF-A
mediates angiotensin II induced cardiac hypertrophy. J Mol Cell
Cardiol. 80:23–33. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Zeisberg EM, Tarnavski O, Zeisberg M,
Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT,
Roberts AB, et al: Endothelial-to-mesenchymal transition
contributes to cardiac fibrosis. Nat Med. 13:952–961. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Liu Y, Gao L, Guo S, Liu Y, Zhao X, Li R,
Yan X, Li Y, Wang S, Niu X, et al: Kaempferol alleviates
angiotensin II-induced cardiac dysfunction and interstitial
fibrosis in mice. Cell Physiol Biochem. 43:2253–2263. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Fan Q, Chen L, Cheng S, Li F, Lau WB, Wang
le F and Liu JH: Aging aggravates nitrate-mediated ROS/RNS changes.
Oxid Med Cell Longev. 2014:3765152014. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Juhaszova M, Zorov DB, Yaniv Y, Nuss HB,
Wang S and Sollott SJ: Role of glycogen synthase kinase-3beta in
cardioprotection. Circ. Res. 104:1240–1252. 2009.
|
|
162
|
Suchal K, Malik S, Gamad N, Malhotra RK,
Goyal SN, Chaudhary U, Bhatia J, Ojha S and Arya DS: Kaempferol
attenuates myocardial ischemic injury via inhibition of MAPK
signaling pathway in experimental model of myocardial
ischemia-reperfusion injury. Oxid Med Cell Longev.
2016:75807312016. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Shen AC and Jennings RB: Kinetics of
calcium accumulation in acute myocardial ischemic injury. Am J
Pathol. 67:441–452. 1972.PubMed/NCBI
|
|
164
|
Guo Z, Liao Z, Huang L, Liu D, Yin D and
He M: Kaempferol protects cardiomyocytes against
anoxia/reoxygenation injury via mitochondrial pathway mediated by
SIRT1. Eur J Pharmacol. 761:245–253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Khader A, Yang WL, Kuncewitch M, Jacob A,
Prince JM, Asirvatham JR, Nicastro J, Coppa GF and Wang P: Sirtuin
1 activation stimulates mitochondrial biogenesis and attenuates
renal injury after ischemia-reperfusion. Transplantation.
98:148–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Zhou M, Ren H, Han J, Wang W, Zheng Q and
Wang D: Protective effects of kaempferol against myocardial
Ischemia/Reperfusion injury in isolated rat heart via antioxidant
activity and inhibition of glycogen synthase kinase-3β. Oxid Med
Cell Longev. 2015:4814052015. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Lei Y, Chen J, Zhang W, Fu W, Wu G, Wei H,
Wang Q and Ruan J: In vivo investigation on the potential of
galangin, kaempferol and myricetin for protection of
D-galactose-induced cognitive impairment. Food Chem. 135:2702–2707.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Zhong SZ, Ge QH, Qu R, Li Q and Ma SP:
Paeonol attenuates neurotoxicity and ameliorates cognitive
impairment induced by d-galactose in ICR mice. J Neurol Sci.
277:58–64. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Palsamy P, Sivakumar S and Subramanian S:
Resveratrol attenuates hyperglycemia-mediated oxidative stress,
proinflammatory cytokines and protects hepatocytes ultrastructure
in streptozotocin-nicotinamide-induced experimental diabetic rats.
Chem Biol Interact. 186:200–210. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
McEwen BS and Stellar E: Stress and the
individual. Mechanisms leading to disease. Arch Intern Med.
153:2093–2101. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Whooley MA and Simon GE: Managing
depression in medical outpatients. N Engl J Med. 343:1942–1950.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Park SH, Sim YB, Han PL, Lee JK and Suh
HW: Antidepressant-like effect of kaempferol and quercitirin,
isolated from opuntia ficus-indica var. saboten. Exp Neurobiol.
19:30–38. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Reeve A, Simcox E and Turnbull D: Ageing
and Parkinson's disease: Why is advancing age the biggest risk
factor? Ageing Res Rev. 14:19–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Tian L, Karimi M, Loftin SK, Brown CA, Xia
H, Xu J, Mach RH and Perlmutter JS: No differential regulation of
dopamine transporter (DAT) and vesicular monoamine transporter 2
(VMAT2) binding in a primate model of Parkinson disease. PLoS One.
7:e314392012. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Han X, Sun S, Sun Y, Song Q, Zhu J, Song
N, Chen M, Sun T, Xia M, Ding J, et al: Small molecule-driven NLRP3
inflammation inhibition via interplay between ubiquitination and
autophagy: Implications for Parkinson disease. Autophagy. 1–22.
2019.10.1080/15548627.2019.1596481 (Epub ahead of print).
View Article : Google Scholar
|
|
176
|
Li S and Pu XP: Neuroprotective effect of
kaempferol against a
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of
Parkinson's disease. Biol Pharm Bull. 34:1291–1296. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Ma Z, Li C, Qiao Y, Lu C, Li J, Song W,
Sun J, Zhai X, Niu J, Ren Q and Wen A: Safflower yellow B
suppresses HepG2 cell injury induced by oxidative stress through
the AKT/Nrf2 pathway. Int J Mol Med. 37:603–612. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Ren R, Shi C, Cao J, Sun Y, Zhao X, Guo Y,
Wang C, Lei H, Jiang H, Ablat N, et al: Neuroprotective effects of
A standardized flavonoid extract of safflower against
neurotoxin-induced cellular and animal models of Parkinson's
disease. Sci Rep. 6:221352016. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Jang JY, Kim HN, Kim YR, Choi YW, Choi YH,
Lee JH, Shin HK and Choi BT: Hexane extract from Polygonum
multiflorum attenuates glutamate-induced apoptosis in primary
cultured cortical neurons. J Ethnopharmacol. 145:261–268. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Yang EJ, Kim GS, Jun M and Song KS:
Kaempferol attenuates the glutamate-induced oxidative stress in
mouse-derived hippocampal neuronal HT22 cells. Food Funct.
5:1395–1402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Lai TW, Zhang S and Wang YT:
Excitotoxicity and stroke: Identifying novel targets for
neuroprotection. Prog Neurobiol. 115:157–188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Zhou X, Sun X, Gong X, Yang Y, Chen C,
Shan G and Yao Q: Astragaloside IV from Astragalus membranaceus
ameliorates renal interstitial fibrosis by inhibiting inflammation
via TLR4/NF-кB in vivo and in vitro. Int Immunopharmacol. 42:18–24.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Zhang H, Park JH, Maharjan S, Park JA,
Choi KS, Park H, Jeong Y, Ahn JH, Kim IH, Lee JC, et al: Sac-1004,
a vascular leakage blocker, reduces cerebral ischemia-reperfusion
injury by suppressing blood-brain barrier disruption and
inflammation. J Neuroinflammation. 14:1222017. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Cheng X, Yang YL, Yang H, Wang YH and Du
GH: Kaempferol alleviates LPS-induced neuroinflammation and BBB
dysfunction in mice via inhibiting HMGB1 release and
down-regulating TLR4/MyD88 pathway. Int Immunopharmacol. 56:29–35.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Wu B, Luo H, Zhou X, Cheng CY, Lin L, Liu
BL, Liu K, Li P and Yang H: Succinate-induced neuronal
mitochondrial fission and hexokinase II malfunction in ischemic
stroke: Therapeutical effects of kaempferol. Biochim Biophys Acta.
1863:2307–2318. 2017. View Article : Google Scholar
|
|
186
|
Zhao J, Shu B, Chen L, Tang J, Zhang L,
Xie J, Liu X, Xu Y and Qi S: Prostaglandin E2 inhibits collagen
synthesis in dermal fibroblasts and prevents hypertrophic scar
formation in vivo. Exp Dermatol. 25:604–610. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Ledon JA, Savas J, Franca K, Chacon A and
Nouri K: Intralesional treatment for keloids and hypertrophic
scars: A review. Dermatol Surg. 39:1745–1757. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Sarrazy V, Billet F, Micallef L, Coulomb B
and Desmoulière A: Mechanisms of pathological scarring: Role of
myofibroblasts and current developments. Wound Repair Regen. 19
(Suppl 1):S10–S15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Li H, Yang L, Zhang Y and Gao Z:
Kaempferol inhibits fibroblast collagen synthesis, proliferation
and activation in hypertrophic scar via targeting TGF-β receptor
type I. Biomed Pharmacother. 83:967–974. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Rietjens IM, Boersma MG, van der Woude H,
Jeurissen SM, Schutte ME and Alink GM: Flavonoids and
alkenylbenzenes: Mechanisms of mutagenic action and carcinogenic
risk. Mutat Res. 574:124–138. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Sheng WY, Chen YR and Wang TC: A major
role of PKC theta and NFkappaB in the regulation of hTERT in human
T lymphocytes. FEBS Lett. 580:6819–6824. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Park SE, Sapkota K, Kim S, Kim H and Kim
SJ: Kaempferol acts through mitogen-activated protein kinases and
protein kinase B/AKT to elicit protection in a model of
neuroinflammation in BV2 microglial cells. Br J Pharmacol.
164:1008–1025. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Wang J, Fang X, Ge L, Cao F, Zhao L, Wang
Z and Xiao W: Antitumor, antioxidant and anti-inflammatory
activities of kaempferol and its corresponding glycosides and the
enzymatic preparation of kaempferol. PLoS One. 13:e01975632018.
View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Noroozi M, Angerson WJ and Lean ME:
Effects of flavonoids and vitamin C on oxidative DNA damage to
human lymphocytes. Am J Clin Nutr. 67:1210–1218. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Bestwick CS, Milne L, Pirie L and Duthie
SJ: The effect of short-term kaempferol exposure on reactive oxygen
levels and integrity of human (HL-60) leukaemic cells. Biochim
Biophys Acta. 1740:340–349. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Sahu SC and Gray GC: Kaempferol-induced
nuclear DNA damage and lipid peroxidation. Cancer Lett. 85:159–164.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Liesveld JL, Abboud CN, Lu C, McNair C,
Menon A, Smith A, Rosell K and Rapoport AP: Flavonoid effects on
normal and leukemic cells. Leuk Res. 27:517–527. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Das A, Majumder D and Saha C: Correlation
of binding efficacies of DNA to flavonoids and their induced
cellular damage. J Photochem Photobiol B. 170:256–262. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Cos P, Calomme M, Sindambiwe JB, De Bruyne
T, Cimanga K, Pieters L, Vlietinck AJ and Vanden Berghe D:
Cytotoxicity and lipid peroxidation-inhibiting activity of
flavonoids. Planta Med. 67:515–519. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Gupta A, Kaur CD and Saraf S and Saraf S:
Formulation, characterization, and evaluation of ligand-conjugated
biodegradable quercetin nanoparticles for active targeting. Artif
Cells Nanomed Biotechnol. 44:960–970. 2016.PubMed/NCBI
|
|
201
|
Qian YS, Ramamurthy S, Candasamy M, Shadab
M, Kumar RH and Meka VS: Production, characterization and
evaluation of kaempferol nanosuspension for improving oral
bioavailability. Curr Pharm Biotechnol. 17:549–555. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Resende FA, Vilegas W, Dos Santos LC and
Varanda EA: Mutagenicity of flavonoids assayed by bacterial reverse
mutation (Ames) test. Molecules. 17:5255–5268. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Polyakov NE and Kispert LD: Water soluble
biocompatible vesicles based on polysaccharides and
oligosaccharides inclusion complexes for carotenoid delivery.
Carbohydr Polym. 128:207–219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Xu W, Wen M, Yu J, Zhang Q, Polyakov NE,
Dushkin AV and Su W: Mechanochemical preparation of kaempferol
intermolecular complexes for enhancing the solubility and
bioavailability. Drug Dev Ind Pharm. 44:1924–1932. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Lemos C, Peters GJ, Jansen G, Martel F and
Calhau C: Modulation of folate uptake in cultured human colon
adenocarcinoma Caco-2 cells by dietary compounds. Eur J Nutr.
46:329–336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Sunoqrot S, Bae JW, Pearson RM, Shyu K,
Liu Y, Kim DH and Hong S: Temporal control over cellular targeting
through hybridization of folate-targeted dendrimers and PEG-PLA
nanoparticles. Biomacromolecules. 13:1223–1230. 2012. View Article : Google Scholar : PubMed/NCBI
|
